Bayer completes $1.1bn Conceptus buy
This article was originally published in Clinica
Executive Summary
Bayer has completed its $1.1bn acquisition of Conceptus, a US firm that developed and markets the Essure birth control method. The deal was announced in April (www.clinica.co.uk, 29 April 2013).